• The State Of Study Startup: 4 Key Themes

    Clinical Research News | A recent study reveals that contract research organizations, while outperforming clinical trial sponsors on multiple fronts, are still struggling when it comes to site performance and overall satisfaction.

    Mar 19, 2019

  • Blockchain’s Potential In Clinical Research

    Clinical Research News | Clinical research is a complex process involving various actors where trust, data sharing, security, and visibility need to be established from clinical trial participants, physicians, researchers, service providers, sponsors, and regulators. This is where blockchain comes in.

    Mar 18, 2019

  • Data-Driven Clinical Research: What We’ll Be Watching At Bio-IT World 2019

    Clinical Research News | As clinical trials gather more data from wearables, patient-reported outcomes, and real-world evidence in addition to traditional streams, systems for managing and using those data are becoming top priority. At the Bio-IT World Conference & Expo there are a host of sessions exploring how this is being done. The Clinical Research News editorial staff is busy marking our programs for the week. 

    Mar 14, 2019

  • Innovation, Quality & Expertise: Keys to the Post-Brexit Clinical Landscape

    Clinical Research News Contributed Commentary | Brexit has, and will continue to have, a profound impact on clinical trials in the UK and throughout Europe. While no one can know precisely what that long-term impact will be, pharma companies must be ready to adjust quickly.

    Mar 13, 2019

  • FDA Commissioner Gottlieb Resigns

    Washington Post | FDA Commissioner Scott Gottlieb, who used his post to tackle difficult public health issues from youth vaping to opioid addiction resigned Tuesday, effective in about a month.

    Mar 7, 2019

  • Microsoft Builds A Bot To Match Patients To Clinical Trials

    Seattle Times | Microsoft's Clinical Trials Bot lets patients and doctors search for studies related to a disease and then answer a succession of text questions to narrow down their availability.

    Mar 6, 2019

  • Taking Down Compliance Barriers with State Prescribing Regs

    Clinical Research News | Nearly all states require physicians to access a prescription drug monitoring program (PDMP) before writing prescriptions for controlled substances to help red-flag opioid “doctor shopping” by patients. But some doctors prefer to trust their gut, or simply can’t find the time. “The level of effort required to consult a PDMP registry is very high, almost prohibitive for physicians,” says G. Cameron Deemer, president of e-prescribing software provider DrFirst.

    Mar 6, 2019